WHO ICTRP trial
A randomized, blind design clinical trial evaluating the immunogenicity and…
ChiCTR2300079076 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300079076 |
|---|---|
| Public title | A randomized, blind design clinical trial evaluating the immunogenicity and safety of the recombinant herpes zoster vaccine (CHO cells) LZ901 compared with a similar positive vaccine in people 50 years of age and older |
| Scientific title | A randomized, blind design clinical trial evaluating the immunogenicity and safety of the recombinant herpes zoster vaccine (CHO cells) LZ901 compared with a similar positive vaccine in people 50 years of age and older |
| Primary sponsor | Jiangsu Center for Disease Control and Prevention (Jiangsu Institute of Public Health) |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Zoster prophylaxis |
| Interventions | Experimental vaccine group:Recombinant herpes zoster vaccine was administered at D0-D30;Control vaccine group:Recombinant herpes zoster vaccine was administered at D0-D60 |
| Registration date | Dec 25, 2023 |
| Target size | Experimental vaccine group:150;Control vaccine group:150 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: